Laxmi Dental

Laxmi Dental

395.60
-5.00
(-1.25%)
Market Cap
2,174.30 Cr
EPS
6.06
PE Ratio
81.96
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
584.00
52 Week Low
313.20
PB Ratio
10.56
Debt to Equity
1.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Laxmi Dental Limited has scheduled an earnings conference call for analysts and institutional investors on August 13, 2025, at 12:00 Noon IST. The call will discuss the company's unaudited financial results for the quarter ended June 30, 2025. The conference call is organized by Motilal Oswal Financial Services Limited and will feature key participants including Chairperson and Whole-Time Director Rajesh Khakhar, Managing Director and CEO Sameer Merchant, and CFO Dharmesh Dattani. The company has provided multiple access numbers for participants and requested pre-registration for the call.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,927.40
#1 19,618.70
57.82
#1 1,434.50
24.59
#1 258
25.81
31.31
395.60
#2 2,174.30
#9 81.96
#4 236.56
#5 19.23
#3 29
#6 -44.16
36.16
356.60
1,897.34
63.59
392.41
-0.45
30
-0.97
32.07
623.05
1,035.62
58.75
249.37
#1 40.00
17
-34.92
50.22
458.00
738.72
35.40
186.47
-
20
-
67.49
535.00
642.20
35.29
63.03
30.58
18
6.25
46.64
155.25
295.60
#1 19.31
136.30
-16.22
16
-
44.20
260.40
273.77
32.59
89.85
0.60
7
#1 841.20
77.00
234.00
244.29
29.82
106.53
-1.43
8
-
85.57
236.98
236.98
-
122.10
19.24
1
-52.94
35.81
Forecast
Actual
Growth Rate
Revenue Growth
19.23 %
Net Income Growth
-506.82 %
Cash Flow Change
-43.56 %
ROE
-276.23 %
ROCE
-4,748.84 %
EBITDA Margin (Avg.)
91.50 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
48
55
67
57
61
63
Expenses
44
44
46
48
52
51
EBITDA
3
11
21
9
9
11
Operating Profit %
6 %
19 %
23 %
14 %
14 %
15 %
Depreciation
3
3
3
3
4
4
Interest
1
1
1
1
2
1
Profit Before Tax
-1
7
16
5
5
6
Tax
-3
-1
-1
-1
-0
2
Net Profit
2
8
17
6
5
4
EPS in ₹
76.30
1.46
6.04
2.12
0.88
0.79

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
106
106
103
97
135
285
Fixed Assets
39
43
40
40
46
51
Current Assets
53
50
60
53
64
187
Capital Work in Progress
0
7
0
0
0
0
Investments
0
0
0
0
6
19
Other Assets
66
57
63
56
83
0
Total Liabilities
106
106
103
97
135
285
Current Liabilities
46
46
59
57
67
57
Non Current Liabilities
11
15
20
20
23
19
Total Equity
49
44
23
20
45
209
Reserve & Surplus
37
33
9
6
31
198
Share Capital
12
12
0
0
0
11

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
0
0
-3
4
-6
Investing Activities
-18
-9
3
-10
-15
Operating Activities
12
10
-2
14
8
Financing Activities
6
-0
-4
-2
1

Share Holding

% Holding
Sept 2024
Jan 2025
Mar 2025
Jun 2025
Promoter
86.61 %
41.70 %
41.70 %
41.70 %
FIIs
0.00 %
29.49 %
34.24 %
33.59 %
DIIs
0.00 %
15.18 %
12.86 %
14.31 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
9.56 %
6.49 %
5.80 %
Others
13.39 %
4.07 %
4.70 %
4.60 %
No of Share Holders
13
13
29,482
27,957

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 394.40 393.80
13 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2025 481.80 429.60

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.1 day ago
Board Comments On Fine Levied By The National Stock Exchange Of India Limited For Non-Compliance With Regulation 23(9) Of The SEBI (LODR) Regulations 2015.Jul 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJul 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 12, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 06, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 27, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 27, 2025
Financial Results For The Financial Year Ended 31St March 2025May 27, 2025
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Laxmi Dental Limited Held On Monday May 26 2025May 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025.May 21, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 20, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 28, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 24, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 16, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 02, 2025
Closure of Trading WindowMar 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 24, 2025
Intimation For Change Of Corporate Identification Number (CIN) And Listing Status Of The Company.Mar 24, 2025
Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 22, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 21, 2025
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Held On Friday March 21 2025.Mar 21, 2025
Disclosure Of Information Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 11, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 25, 2025
Update - Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024 In Machine Readable Form/ Legible CopyFeb 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Feb 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025

Technical Indicators

RSI(14)
Neutral
36.16
ATR(14)
Less Volatile
18.42
STOCH(9,6)
Oversold
8.82
STOCH RSI(14)
Oversold
1.57
MACD(12,26)
Bearish
-7.35
ADX(14)
Weak Trend
22.51
UO(9)
Bearish
33.73
ROC(12)
Downtrend And Accelerating
-16.46
WillR(14)
Oversold
-96.04

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Invesco India Smallcap Fund Direct - Growth
0.00%
-1153842
-0.68%
-0.65%
Quant Flexi Cap Fund Direct-Growth
0.00%
-496758
-0.29%
-0.04%
Bank of India Small Cap Fund Direct-Growth
0.00%
-449000
-1.02%
-0.95%
Mirae Asset Healthcare Fund Direct - Growth
0.00%
-407121
-0.64%
-0.58%
Quant Dynamic Asset Allocation Fund Direct - Growth
0.00%
-394066
-1.36%
-1.21%
Quant Healthcare Fund Direct - Growth
0.00%
-290091
-2.96%
-0.50%
DSP Healthcare Fund Direct - Growth
0.00%
-280401
-0.40%
-0.36%
Kotak Consumption Fund Direct - Growth
0.00%
-263544
-0.86%
-0.81%
TRUSTMF Small Cap Fund Direct-Growth
0.00%
-231854
-0.98%
-0.92%
Quant Manufacturing Fund Direct - Growth
0.00%
-210617
-1.05%
-0.53%
Kotak Healthcare Fund Direct - Growth
0.00%
-210010
-2.01%
-1.85%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.18%
-208866
-0.18%
-0.15%
Bandhan Small Cap Fund Direct-Growth
0.00%
-160866
-0.05%
-0.05%
Quant Small Cap Fund Direct Plan-Growth
0.00%
-139893
-0.02%
-0.02%
WhiteOak Capital Multi Cap Fund Direct - Growth
0.00%
-129612
-0.27%
-0.26%
UTI Healthcare Fund Direct-Growth
0.56%
-82986
-0.37%
-0.29%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
-58460
-0.70%
-0.68%
HSBC India Export Opportunities Fund Direct-Growth
1.08%
-54012
-0.13%
0.00%
LIC MF Focused Fund Direct - Growth
1.36%
53008
1.36%
1.36%
WhiteOak Capital Balanced Advantage Fund Direct - Growth
0.00%
-39294
-0.10%
-0.10%
WhiteOak Capital Multi Asset Allocation Fund Direct - Growth
0.00%
-35729
-0.06%
-0.06%
WhiteOak Capital ELSS Tax Saver Fund Direct - Growth
0.00%
-27361
-0.29%
-0.27%
WhiteOak Capital Balanced Hybrid Fund Direct - Growth
0.00%
-1929
-0.04%
-0.04%
HDFC Pharma And Healthcare Fund Direct - Growth
1.40%
0
-0.17%
-0.05%
Tata India Pharma & Healthcare Fund Direct-Growth
0.05%
0
0.00%
0.01%